Jefferies Upgrades Abivax (ABVX) to Buy

June 30, 2026 4:11 PM

Jefferies analyst Faisal Khurshid upgraded Abivax (NASDAQ: ABVX) from Hold to Buy with a price target of $158.00 (from $108.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found